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Pasteurella multocida Endocarditis with Septic 
Arthritis: Case Report and Review of the Literature
Abstract
Background: There is a paucity of evidence regarding optimal management of Pasteurella 
spp. endocarditis. The authors report the first case of Pasteurella spp. endocarditis with 
septic arthritis and review the literature.
Case Description: A 79-year-old patient with significant comorbidities, including prosthetic 
aortic valve, was admitted with left knee swelling, fever, and confusion, having been 
scratched by a cat 2-weeks prior. At presentation, there was a metallic click, a Grade 3 
pan-systolic murmur and Grade 1 flow murmur audible on auscultation. Blood and synovial 
fluid cultures both isolated Pasteurella multocida, identified by matrix-assisted laser 
desorption ionisation–time of flight, which was sensitive to penicillin according to the 
European Committee on Antimicrobial Susceptibility Testing (EUCAST); minimum inhibitory 
concentration: 0.094). The patient underwent joint washout and received intravenous 
piperacillin/tazobactam for 3 days before switching to benzylpenicillin once sensitivities 
were known. Due to continued pyrexia, a transthoracic echocardiogram was obtained, 
which revealed a small mobile mass on a thickened mitral valve suspicious for a vegetation. 
On review by the Infective Endocarditis team, conservative management was deemed 
best, given the presence of comorbidities. Despite requiring further joint washout due to 
persistent knee pain, the patient was successfully treated with 8 weeks of antibiotic therapy 
(24 days of benzylpenicillin monotherapy, 2 weeks of benzylpenicillin and ciprofloxacin, and 
15 days ciprofloxacin monotherapy).
Discussion: Previous literature reviews report a higher mortality of Pasteurella spp. 
endocarditis when managed without cardiac surgery, thus recommending surgery in all 
cases. The authors found these to have confounding factors, including inadequate duration 
of antimicrobials, aortic root abscess, and rapid progression to death. The authors’ case of 
Pasteurella spp. endocarditis, complicated by septic arthritis, showed successful therapy 
without cardiac surgery.
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BACKGROUND
Pasteurella multocida (formerly Pasteurella 
septica) is a gram-negative aerobic and 
facultatively anaerobic coccobacillus. It is 
non-motile, non-sporing, capsulated, and acts as a 
commensal or opportunistic pathogen in a variety 
of animal species. Animal to human transmission 
occurs occasionally, following a break in tissue 
leading to transmission of the bacteria from the 
animal to the human. This can be in the form of 
bites or scratches. Human infections commonly 
present as a localised abscess or cellulitis and in 
severe cases, osteomyelitis. Rare manifestations 
include meningitis, pericarditis, blood stream 
infection or infective endocarditis.1 
P. multocida infections usually respond to 
penicillin, with tetracyclines, macrolides, 
and cotrimoxazole as possible alternatives 
with patients who are allergic to penicillin. 
Treatment of invasive infections such as infective 
endocarditis is challenging because of the rarity 
of the condition and a lack of evidence to inform 
treatment, especially in patients where a surgical 
approach is not suitable. 
In this report, the authors describe a case 
of prosthetic valve P. multocida infective 
endocarditis, which was treated conservatively.
CASE PRESENTATION
A 79-year-old patient presented to hospital 
with history of left knee swelling, pain, 
increased confusion, poor appetite, and 
pyrexia. Collateral history obtained from their 
spouse revealed a cat scratch 2 weeks prior 
to presentation. Past medical history included 
metallic aortic valve replacement, tissue 
mitral valve replacement, a pacemaker, Type 
2 diabetes, Alzheimer’s dementia, anxiety, 
breast cancer, and endometrial cancer with 
hysterectomy (2001). At initial presentation, 
clinical examination showed an alert and 
mildly confused patient with a temperature of 
37.9oC. There were no peripheral stigmata of 
infective endocarditis; however, a metallic click, 
consistent with the replaced aortic valve, a 
Grade 3 mitral pan-systolic murmur, and Grade 
1 aortic flow murmurs were both audible on 
auscultation. There were no signs of pulmonary 
oedema or aortic regurgitation. The left knee 
was swollen, warm to touch with limited flexion 
and extension of the joint, and a working 
diagnosis of septic arthritis was made. 
Blood cultures were taken, and a 
gram-negative bacillus was identified on the 
initial blood culture gram stain. Input from the 
microbiology team advised that the patient 
be switched from empirical intravenous (IV) 
flucloxacillin to IV piperacillin-tazobactam 
to provide adequate gram-negative cover. 
On matrix-assisted laser desorption 
ionisation–time of flight (MALDI-TOF) testing, 
P. multocida was identified from the blood 
cultures. The patient was taken to theatre 
for aspiration and washout of the knee joint. 
The knee joint aspiration produced purulent 
synovial fluid and P. multocida was cultured 
from synovial and tissue samples sent from 
the knee (identified using MALDI-TOF). 
The isolate was found to be susceptible to 
penicillin on to the European Committee 
on Antimicrobial Susceptibility Testing 
(EUCAST) disc sensitivities and subsequent 
penicillin minimum inhibitory concentration of 
0.094 mg/L; therefore, the patient was switched 
to IV of benzylpenicillin of 1.2 g every 6 hours. 
The patient remained pyrexial, despite being 
on the appropriate antibiotics and joint 
washout, prompting the arrangement of a 
transthoracic echocardiogram to look for 
other sources of deep-seated infection. This 
showed a small mobile mass on the mitral 
valve, consistent with a vegetation (Figure 1). 
The non-microbiology investigations for this 
case and timeline to diagnosis of suspected 
endocarditis are summarised in Table 1. 
The case was reviewed by the infective 
endocarditis team and discussed thereafter 
at the cardiac multidisciplinary team 
meeting. Due to significant comorbidities, 
transoesophageal echocardiography and 
cardiac surgery were deemed not to be suitable 
in this case. It was agreed that management 
should be conservative with transthoracic 
echocardiograms for imaging follow-up. 
The patient was treated with benzylpenicillin 
monotherapy for 24 days, but dosing frequency 
was increased from 1.2 g every 6 hours to 1.2 g 
every 4 hours on Day 30 because of persisting 
pyrexia. Oral ciprofloxacin, 500 mg every 
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Figure 1: Echocardiogram images showing mitral valve with small mobile mass suspicious of vegetation. 
Table 1: Non-microbiology investigations in a patient presenting with Pasteurella multocida septic arthritis and 
infective endocarditis.
AVR: aortic valve replacement; LV: left ventricle; MV: mitral valve; MVR: mitral valve replacement; RV: right ventricle; 
TR: tricuspid regurgitation; TTE: transthoracic echocardiography.
Days from time of 
clinical presentation
Investigation Results and findings
1 Knee X-ray Moderate volume joint effusion, several medial tibiofemoral and 





Copious purulent fluid from the joint
Washed out and sent to microbiology
3 TTE Metallic AVR in situ
Tissue MVR in situ
Small, mobile mass on MV, consistent with vegetation
Preserved LV systolic function
Moderate RV systolic impairment.
Severe TR
Pulmonary hypertension and moderate bi-atrial dilation
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12 hours, was then added as a second agent based 
on static raised C-reactive protein and ongoing 
knee pain (P. multocida isolate was susceptible 
to ciprofloxacin). The patient had a further joint 
washout 35 days after commencement of IV 
benzylpenicillin. On Day 40, IV benzylpenicillin 
was stopped, ciprofloxacin monotherapy 
continued, and the indwelling vascular long line 
was replaced with a peripheral cannula. Repeat 
blood cultures and synovial fluid cultures from 
this point onwards were negative. The patient 
continued to make a good recovery following this 
and was discharged to a nursing home following 
a 60-day inpatient stay, without need for further 
orthopaedic or cardiology follow-up. The total 
duration of effective antibiotics was 56 days 
(8 weeks). This included 3 days on IV piperacillin-
tazobactam, 24 days of IV benzylpenicillin 
monotherapy, 2 weeks on dual agent therapy 
of benzylpenicillin and oral ciprofloxacin and 15 
days on ciprofloxacin monotherapy. 
LITERATURE REVIEW
Method
A local database of all infective endocarditis 
cases at Leeds Teaching Hospital Trust, UK, was 
searched for cases involving Pasteurella spp. 
and this case was the only one identified since 
1998. A literature search was conducted via 
PubMed using the search terms ‘Pasteurella’ 
AND ‘endocarditis’. Further references were 
then identified from the references used in these 
papers. Only case reports written in English, 
French, or Spanish were included in the analysis, 
due to the availability of interpretation services. 
The modified Duke’s criteria2 were applied to 
these case reports and papers were included 
if they met the criteria for definite or possible 
infective endocarditis caused by Pasteurella spp. 
Results of the Literature Search
The search identified 28 papers and searching 
by citation identified a further six papers 
(Table 2). Of these, 32 papers met the authors' 
inclusion criteria (including case in this article), 
31 described cases that met Duke’s criteria 
for a definite diagnosis and one met the 
criteria for possible diagnosis of Pasteurella 
endocarditis.11 Of these there were 24 cases 
of P. multocida endocarditis,3-10,14-19,21-23,31-33 
seven cases of non-multocida Pasteurella 
endocarditis,9,21,26-28,30,31 and one case of 
undifferentiated Pasteurella endocarditis.7 
Seven cases (21%) had prosthetic valve 
endocarditis,6,18-21,27 while 17 patients (53%) had a 
predisposing cardiac condition3,6,7,10,13,14,18,19,20,21,23,25,27 
and 17 (53%) had other underlying comorbidities 
reported.3,5,6,10,14,-16,19,22,26,27,29-31 Twenty-one 
patients (66%) had documented animal 
exposure,3,4,6,8,10,11,13,14,16-20,22,25-29  of which 10 (31%) 
reported a bite, scratch, or contact of saliva with 
broken skin. 
Fever was the most common presenting 
symptom, afffecting 31 patients (97%), and 
18 patients (56%) presented with systemic 
upset. Only 16 (50%) had a cardiac murmur on 
initial presentation but 24 (75%) developed 
complications, including 5 (16%) with aortic root 
abscess and 13 (41%) with septic emboli. 
The diagnosis of infective endocarditis was 
missed in seven patients (22%) and diagnosed 
on representation. Although the majority of 
patients presented within 7 days of symptom 
onset, nine patients (28%) presented with a 
more prolonged history of general malaise, the 
longest being 3 months.10
Of the Pasteurella isolates, 19 patients (59%) 
had susceptibility testing results reported and, 
of these, only one case reported penicillin 
resistance.5 Antibiotic therapy included a 
β-lactam antibiotic in the majority of cases (24 
patients, 75%). Of the four patients who received 
penicillin or aminopenicillin monotherapy for the 
duration of treatment, three underwent valve 
surgery. Only one case had a reported allergy 
to penicillin and was treated successfully with 6 
weeks of IV ceftriaxone.22 
One patient with Pasteurella pneumotropica 
endocarditis of a native tricuspid valve was 
successfully treated with 6 weeks of ciprofloxacin 
monotherapy without surgery.27 Duration of 
treatment was reported in 25 cases (78%). Of 
these cases, 20 patients (80%) received at least 
4 weeks of antibiotic therapy, with a median 
duration of 6 weeks (range: 1 day–20 weeks). 
Median duration of antibiotic therapy in patients 
who did not have surgery and survived was 
5.8 weeks. Of the patients who did not survive, all 
apart from one were still on antimicrobial therapy 
when they died.5
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Fourteen patients (44%) underwent valve 
replacement surgery, and one was awaiting 
surgery. Indications for surgery included aortic 
root abscess in four patients (33%), severe 
valvular regurgitation in seven (42%), and 
persistent fever in three (17%). Five out of seven 
(71%) cases of prosthetic valve endocarditis were 
treated successfully, with three achieving cure 
on antibiotics alone, whilst the other two cases 
underwent surgical intervention. 
Overall mortality rate from these cases was 19% 
(6/32). The mortality rate with surgery was 7% 
(1/14) and without surgery was 28% (5/18). Of 
the cases who died without surgery, two died 
within 24 hours of presentation and infective 
endocarditis was diagnosed at post-mortem 
examination;13,19 one had an aortic root abscess, 
a concurrent bacteraemia with Burkholderia 
cepacia and a candidaemia;6 one received only 
2 weeks of antibiotics and then died later from 
heart failure;6 and one of the patients died 9 
days prior to an operation being performed from 
severe heart failure.31 The patient who died after 
surgery presented with recurrence of infective 
endocarditis 6 weeks after his initial operation. 
The patient then represented after 4 months 
with a pseudomonal mitral and aortic valve 
endocarditis and died shortly after a further 
operation.20 Of the cases who did not have 
surgery, 14 (88%) had underlying comorbidities 
compared with eight of the cases (57%) who did 
have surgery.
DISCUSSION
A literature search found P. multocida to 
be a very rarely reported cause of infective 
endocarditis, with only 31 cases in the English 
language literature. The patient the authors’ 
described was the first to be seen in their 
institution for over 20 years. This patient was 
also the first to suffer from septic arthritis as 
a complication. Although the authors’ patient 
was successfully treated without surgery, they 
needed 8 weeks of antibiotics and the septic 
arthritis did not respond well to penicillin, 
requiring the addition of ciprofloxacin. 
A recent analysis of Pasteurella spp. infective 
endocarditis cases concluded that all patients 
should be offered surgical intervention, unless 
an absolute contraindication exists given the 
difference in mortality rate.19 However, they 
did not include a patient who died 4 months 
post-valve replacement from early prosthetic 
valve endocarditis caused by Pseudomonas 
aeruginosa.20 The analysis was also limited by 
a lack of consideration of confounding factors 
such as comorbidity, which would skew the 
outcome in favour of surgery as surgical 
cases had a lower incidence of comorbidities. 
Furthermore, they did not adjust for severity 
of illness at presentation, nor whether existing 
guidelines were followed when considering 
surgical intervention. Therefore, the authors 
would suggest, as with other bacterial 
causes of infective endocarditis, that surgical 
intervention is not indicated in all cases, and 
should be decided on a case-by-case basis.
It is difficult to draw conclusions from the 
available literature as to the optimal choice 
and duration of antimicrobial therapy due to 
the significant variation in practice and the 
lack of reporting of antimicrobial susceptibility 
data or duration of antimicrobials. The authors’ 
patient received an initial 24 days of penicillin 
monotherapy; however, due to persistent 
pyrexia and knee pain, the dose frequency of 
penicillin was increased, and oral ciprofloxacin 
was added. The patient improved clinically 
after this, but this could be attributed to a 
further joint washout. Although the patients 
required 8 weeks of therapy, this prolonged 
duration was likely required due to the 
infected joint. Based on the average duration 
of antibiotic therapy of 5.8 weeks in patients 
who survived without surgery, the authors 
would recommend 6 weeks of antibiotic 
therapy, depending on clinical response.
In summary, the authors have reported a 
patient who, despite significant comorbidities, 
including a pre-disposing cardiac condition, 
was successfully treated for P. multocida 
endocarditis and concurrent septic arthritis 
with an 8-week course of single and dual agent 
therapy of both penicillin and ciprofloxacin, 
without the need for cardiac surgery. It 
would be useful for future case reports to 
clearly document treatment duration as well 
as the indication for surgery or rationale for 
not performing surgery in order to build an 
evidence-base for treatment. The authors 
suggest that patients with Pasteurella spp. 
endocarditis can be managed according to 
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available infective endocarditis guidelines, which 
include the involvement of a dedicated infective 
endocarditis team, who assess the need for 
surgical intervention on a case-by-case basis. This 
adds to the small number of case reports in the 
literature that describe successful management of 
Pasteurella spp. endocarditis and may help inform 
other clinicians when they encounter similar cases. 
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